🇺🇸 FDA

Intelligence Platform

Patents

Browse 738 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8133904

Cannabinoid receptor antagonists/inverse agonists useful for treating obesity

Jenrin Discovery, LLC · Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8124802

MAO inhibiting N-benzyl-N-propargyl-amines useful for treating obesity

Jenrin Discovery, LLC · Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8088798

Cannabinoid receptor antagonists/inverse agonists useful for treating obesity

Jensen Discovery, Inc. · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8088926

Substituted 2-methyl-2-phenoxy-N-propyl-propionamides as cannabinoid receptor antagonists/

Jenrin Discovery, LLC · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8088809

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders,

Jenrin Discovery, LLC · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8008038

Methods for determining oxygen concentration with protoporphyrin IX

ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7994191

Heterocyclic cyclopamine analogs and methods of use thereof

Infinity Discovery, Inc. · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7994299

Compositions and methods for increasing bone mineralization

Darwin Discovery Limited · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7994211

Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses

Argenta Discovery Limited · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7985748

ALPHA2C adrenoreceptor agonists

Pharmacopeia Drug Discovery, Inc. · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7977312

Compositions and methods for increasing bone mineralization

Darwin Discovery Limited · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7964646

3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

Pharmacopeia Drug Discovery, Inc. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7964590

Cyclopamine lactam analogs and methods of use thereof

Infinity Discovery, Inc. · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7956220

MAO-B inhibitors useful for treating obesity

Jenrin Discovery, LLC · Granted Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7947720

3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

Pharmacopeia Drug Discovery, Inc. · Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7928138

Marine actinomycete taxon for drug and fermentation product discovery

The Regents of the University of California · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7928244

Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

Infinity Discovery, Inc. · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7927634

Compositions and methods for treating angiogenesis-related diseases, wounds and cosmetic u

Sunny BioDiscovery · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919246

SEMA4D in cancer diagnosis, detection and treatment

Sagres Discovery, Inc. · Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919583

Integration-site directed vector systems

Discovery Genomics, Inc. · Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7906482

Anti-obesity agents

Advanced Diagnostics and Discovery · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7906491

Compounds for modulating the activity of exchange proteins directly activated by cAMP (Epa

Univisitair Medisch Centrum Utrecht · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7892730

Compositions and methods for cancer

Sagres Discovery, Inc. · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7879838

Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity

Pharmacopeia Drug Discovery, Inc. · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted